Long-term follow-up after transoral outlet reduction following Roux-en-Y gastric bypass: Back to stage 0?
Endoscopy International Open · 01.05.2023 · 11 (05) · E538-E545
DOI: 10.1055/a-2075-1198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.05.2023. Verfasst von Vitor Ottoboni Brunaldi und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Sao Paulo Faculty of Medicine, Gastrointestinal Endoscopy Unit, Gastroenterology Department, Sao Paulo, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims Significant weight regain affects up to one-third of patients after Roux-en-Y gastric bypass (RYGB) and demands treatment. Transoral outlet reduction (TORe) with argon plasma coagulation (APC) alone or APC plus full-thickness suturing TORe (APC-FTS) is effective in the short term. However, no study has investigated the course of gastrojejunostomy (GJ) or quality of life (QOL) data after the first post-procedure year. Patients and methods Patients eligible for a 36-month follow-up visit after TORe underwent upper gastrointestinal endoscopy with measurement of the GJ and answered QOL questionnaires (RAND-36). The primary aim was to evaluate the long-term outcomes of TORe, including weight loss, QOL, and GJ anastomosis (GJA) size. Comparisons between APC and APC-FTS TORe were a secondary aim.
Results
Among 39 eligible patients, 29 returned for the 3-year follow-up visit. There were no significant differences in demographics between APC and APC-FTS TORe groups. At 3 years, patients from both groups regained all the weight lost at 12 months, and the GJ diameter was similar to the pre-procedure assessment. As to QOL, most improvements seen at 12 months were lost at 3 years, returning to pre-procedure levels. Only the energy/fatigue domain improvement was kept between the 1- and 3-year visits.
Conclusions
Obesity is a chronic relapsing disease. Most effects of TORe are lost at 3 years, and redilation of the GJA occurs. Therefore, TORe should be considered iterative rather than a one-off procedure.
Autor:innen und Institutionen
- University of Sao Paulo Faculty of Medicine, Gastrointestinal Endoscopy Unit, Gastroenterology Department, Sao Paulo, Brazil.
- Mayo Clinic, Gastroenterology and Hepatology Department, Rochester, Minnesota, United States.
ORCID-Profile: Vitor Ottoboni Brunaldi, Guilherme Henrique Peixoto de Oliveira, Anthony Kerbage, Galileu Faria, Diogo de Moura, Eduardo de Moura
Zitieren
APA
Brunaldi, V. O., Peixoto de Oliveira, G. H., Kerbage, A., Ribas, P. H., Nunes, F., Faria, G., de Moura, D., Riccioppo, D., Santo, M., & de Moura, E. (2023). Long-term follow-up after transoral outlet reduction following Roux-en-Y gastric bypass: Back to stage 0?. Endoscopy International Open, 11(05), E538-E545. https://doi.org/10.1055/a-2075-1198
Vancouver
Brunaldi VO, Peixoto de Oliveira GH, Kerbage A, Ribas PH, Nunes F, Faria G, et al. Long-term follow-up after transoral outlet reduction following Roux-en-Y gastric bypass: Back to stage 0?. Endoscopy International Open. 2023;11(05):E538-E545. doi:10.1055/a-2075-1198
BibTeX
@article{Brunaldi2023,
author = {Brunaldi, Vitor Ottoboni and Peixoto de Oliveira, Guilherme Henrique and Kerbage, Anthony and Ribas, Pedro Henrique and Nunes, Felipe and Faria, Galileu and de Moura, Diogo and Riccioppo, Daniel and Santo, Marco and de Moura, Eduardo},
title = {Long-term follow-up after transoral outlet reduction following Roux-en-Y gastric bypass: Back to stage 0?},
journal = {Endoscopy International Open},
year = {2023},
volume = {11},
number = {05},
pages = {E538--E545},
doi = {10.1055/a-2075-1198}
}
EUVIMED